Summary.-Acute inflammatory reactions were induced in rats by the intravenous injection of cellulose sulphate (CS) or The mechanisms which may be responsible for the nonspecific growth promoting effects of inflammatory reactions induced by various types of tissue injury on tumour induction and growth are discussed.
Summary.-Acute inflammatory reactions were induced in rats by the intravenous injection of cellulose sulphate (CS) or an extract of normal rat lung homogenate (LH) , or by intraperitoneal injections of Compound 48/80. These treatments greatly increased survival and clonogenic growth in the lungs of rats of intravenously injected allogeneic W-256 and Y-P388 tumour cells. Increase in the dose of intravenously injected CS caused a logarithmic increase in colony forming efficiency (CFE) of tumour cells in the lungs. CFE was not stimulated by the intravenous injection of rats with pharmacological mediators of inflammation (histamine, 5-hydroxytryptamine, bradykinin and prostaglandins PGE1 and PGF2a) which are released from tissues by agents which induce inflammation. Stimulation of CFE by CS occurred in adrenalectomized rats but was inhibited by treatment of rats with an anti-inflammatory steroid, dexamethasone. CFE was stimulated by CS in tumour immunized rats; the inflammatory state did not prevent the expression of immunity but " rescued " a proportion (approximately 20%) of the injected tumour cells from immunodestruction in the lungs. A higher proportion of tumours grew in the paws of rats when a small number of W-256 cells were injected interdigitally into the acute inflammatory swellings produced by the local injection of paws with LH or CS.
CS is a " synthetic heparin " which causes marked prolongation of blood clotting time and also increases fibrinolytic activity of the blood. Anticoagulant treatment of rats with heparin did not affect CFE. Thus, there was no direct correlation between blood clotting time and CFE of blood borne tumour cells in the rat.
The mechanisms which may be responsible for the nonspecific growth promoting effects of inflammatory reactions induced by various types of tissue injury on tumour induction and growth are discussed.
THE PROPORTION of intravenously injected allogeneic tumour cells which survived and formed macrocolonies in the lungs of rats (colony forming efficiency, CFE) is relatively small (less than 1%), but CFE was greatly increased if the lungs of recipients had been treated locally with x-ravs before the tumour cells were injected (van den Brenk, Sharpington and Orton, 1973a; van den Brenk et al., 1973b) . In mice, local x-irradiation of the lungs also stimulated CFE of intravenously injected syngeneic tumour cells (Withers and Milas, 1973) . Stimulation of CFE in the lungs of rats by x-radiation was inhibited by treatment with steroidal and non-steroidal anti-inflammatory drugs (van den Brenk et al., 1974) . These findings suggested that inflammatory reactions produced by x-rays in lung tissues were largely responsible for stimulation of clonogenic growth of tumour cells in the organ.
In this paper we describe experiments in which tumour CFE was measured in rats which were injected with Compound 48/80, cellulose sulphate (CS) and with a preparation of normal rat lung homogenate (LH), which are agents that induce inflammatorv reactions in tissues by releasing autacoids, including histamine, 5-hydroxytryptamine, bradykinin and prostaglandins, which act as pharmacological mediators of inflammation (Brocklehurst, 1971; Di Rosa, Giroud and Willoughby, 197 1).
MATERIALS AND METHODS
Female Caworth Farm strain (SPF) rats -were injected intravenously with single cell suspensions of Walker (W-256) or Yoshida (Y-P388) tumour cells. Lung tumour macrocolonies were counted on the surfaces of the lungs 7-8 days later, as described previously (van den Brenk et al., 1973a) . The number of macrocolonies (NL) (Paton, 1951) and also 5-hydroxytryptamine, another mediator of inflammation (Lewis, 1958 (Lowry et al., 1951 The maximum inflammatory reaction produced in each paw was scored semi-quantitatively as: no effect (0), definite reddening, warmth and swelling (+) (ii) Systemic effects and toxicity.-Cornpound 48/80 injected intraperitoneally in doses of 100 ,ag or more causes mast cell rupture, accompanied by the release of biogenic amines particularly histamine and 5-hydroxytryptamine (Lewis. 1958) ; depletion is followed by resynthesis of the autacoids in the tissues (Paton, 1951; Riley and West, 1955) . Compound 48/80 caused hypotension, pulmonary oedema and an anaphylactic shock-like state attributed principally to the release of tissue histamine; rats injected with larger doses (.500-1000 jag) 48/80 died from haemorrhagic pulmonary oedema. Rats injected with 5-10 mg CS/kg bodv weight rapidly showed signs of shock and dyspnoea but survived; rats injected with > 10 mg CS/kg body weight died from pulnionary haemorrhage and oedema. CS does not release histamine but depletes plasma kininogen and causes the release of the peptide bradykinin. a mediator of inflammation which is also largely responsible for the toxic effects of intravenously injected CS; CS strongly inhibits clotting of the blood and increases the fibrinolytic activity of the blood (Rothschild, 1968) . We found that PGE1 and PGF2a and bradykinin had no significant effects oni blood clotting time. Compound 48/80 slightly shortened clotting time in the rat. CS added to rat blood in vitro prolonged clotting time, which was similarly increased in the blood taken from rats which had been injected with CS ( Fig. 1) . The fibrinolytic effeet of CS is most marked in rats injected with 1-3 mg CS/kg body weight; further increase in dose to 10 mg CS/kg causes fibrinolytic activity to decrease to normal, whereas the anticoagulant effect of the agent continues to increase with increase in dose (Rothschild. 1968, Fig. 1 (Table I ). The greatest increase in CFE (accompanied by -1400% increase in lung weight due to tumour growth) occurred when CS was injected 10 min before the tumour cells. Stimulation of CFE was decreased when CS was injected 2 h before or after the tumour cells, but CFE was significantly raised even when the cells were injected 24 h after CS. CS had no significant effect on CFE when it was injected 24 h after the tumour cells. Consequently, the degree of stimulation of CFE by CS appeared to depend on the presence and intensity of the physiological reaction (inflammation) induced in the rat at the time of injection and implantation of the tumour cells, or in the first few hours after seeding in the tissues; as the inflammatory reaction resolved, CFE decreased pari passu. Compound 48/80 injected, intraperitoneally in maximum tolerated dosage, also enhanced CFE but to a lesser extent than CS. An intravenous injection of LH also stimulated CFE (Table II) . CS and Compound 48/80 also stimulated CFE in rats which were 6 weeks old (Table I, Fig. 2) . Between 4 and 6 weeks of age, CFE of tumour cells in the lungs and other organs of the rat has been shown to decrease markedly, even if assays are performed in rats given sublethal whole body irradiation to suppress immunity (van den Brenk et al., 1973a) . Stimulation of CFE by CS was dose-dependent (Fig. 3) . The dose-effect relationship for CS on CFE correlates with the effect of CS of inhibiting haemocoagulation ( al., 1973a) . This method of immunization was based on that of Haddow and Alexander (1964) for growth of immunogenic methyleholanthrene induced sarcomata in the rat. These workers found that the immunity produced in the rat by a growing tumour was much greater than that produced by repeated injections of large numbers (106-107) of heavily (lethally) irradiated (HR) cells over a period of time. Table IV shows that in rats immunized by the growth of a primary challenge of W-256 cells in leg muscle, CS did not reverse the effects of immunity on the growth of a secondary challenge-a finding which parallels that obtained when local thoracic irradiation was used to stimulate CFE of allogeneic tumour cells in the lungs of rats (van den Brenk et al., 1973b) . The fact that CS increased CFE by a factor of -, 15 in unimmunized and in immunized rats alike is taken to reflect a competition between the inflammatory state induced by CS and that of immunity on tumour growth; each mechanism would appear to act independently on survival and growth of tumour cells. It is significant that while inflammation did not directly antagonize the action of tumour immunity, it protected a proportion of newly seeded tumour cells from immunodestruction for the time needed for these cells to clone and thus increase CFE. Marked splenic enlargement, which is produced in immunized rats by the growth of tumour, was not affected by CS, neither did immunization or CS significantly affect the weight of the thymus (Table IV) Day + 8 weighing 2-5 g, and small (< 1 g) to large (> 2 g) metastases in pelvic lymph nodes; there was no significant difference between the 2 subgroups with respect to growth of the primary tumours or of lymph node metastases. CFE in adrenalectomized rats CFE of W-256 cells in the lungs of totally adrenalectomized rats was slightly reduced (P < 0.05). This reduction in CFE may be related to inhibition of rate of body growth after total adrenalectomy (Table V) . Bilateral medullary adrenalectomy had less effect on both body growth and on tumour CFE. Neither total nor medullary adrenalectomy prevented stimulation of CFE by CS. This suggests that the effect of CS on CFE is not due A~ to the stress syndrome (Selye, 1950) associated with the systemic release of hormones (including adrenaline) from the adrenals.
Reduction of effect of CS on CFE by dexamethasone A large single dose of 2 mg dexamethasone, an anti-inflammatory steroid, injected intramuscularly 2 h before the injection of CS, markedly reduced the effect of CS on CFE (Table IV) .
Assays of W-256 cells incubated with CS, LH and mediators of inflammation
W-256 cells were incubated with 0*2 mg CS per ml of medium. This concentration of CS (2 x 10-4 g per ml) was chosen as approximately equal to the mean concentration of CS produced in the blood of rats by the intravenous injection of the maximum tolerated dose of 10 mg CS per kg body weight, assuming that the agent is distributed uniformly in the blood and the blood volume of the rat is approximately 50 ml blood per kg body weight. Rats injected intravenously with 104 W-256 cells incubated with CS developed 27 + 7 lung colonies, compared with 45 ± 27 colonies in rats injected with 104 cells which had been incubated without CS. It is concluded that CS had no direct effect on the survival or clonogenicity of W-256 cells. Similarly, CFE of W-256 cells incubated with LH or with the mediators histamine, 5-hydroxytryptamine and bradykinin, was not significantly different from that of cells incubated without the addition of these agents (results not tabulated). The final concentration (10-4 g per ml) of the mediators present in the-incubation medium greatly exceeded the local tissue concentrations required to induce inflammatory oedema in rats, and the maximum doses tolerated by rats (measured as dose per unit body weight) when the drugs were administered parenterally. The mediators tested in vitro on sensitive preparations of contractile rat and guineapig tissues (including granulation tissue) induced maximum contractile responses at a concentration of less than 10-4 g per ml in the test bath (unpublished data; Gaddum, 1949; Majno et al., 1971 ).
Effect of anticoagulant treatment with heparin on CFE Anticoagulation treatment of rats with preservative-free heparin had no significant effect on CFE (Table VI) , even if the rats had been given local thoracic * X-radiation technique has been described previously (van den Brenk et al., 1973b). irradiation 7 days before the cells were injected to increase CFE as described previously (van den Brenk et al., 1973b) .
Similarly, CFE was not affected by intraperitoneal injection of rats with 250 i.u. heparin 10 min before the tumour cells were injected intravenously; the results of this experiment were essentially similar to those shown in Table V and are not tabulated.
However, it was found that when 250 i.u. heparin containing 015a% chlorocresol as preservative was added to the tumour cells, CFE was markedly reduced. On the other hand, CFE was not significantly affected by the same dose of heparin (containing the preservative) if it was injected intraperitoneally 10 min before the intravenous injection of tumour cells. Lung colony assays performed with tumour cells which had been incubated with 10-6 concentrations of chlorocresol for 30 min showed that this substance is highly toxic to tumour cells and reduced CFE (unpublished data). The toxic effects of the preservative employed in preparing most brands of heparin used in medicine may account for some experimental findings in which treatment with this anticoagulant was found to cause modest reductions in growth of injected tumour cells and in the development of metastases.
Subcutaneous growth of tumour in inflaned paw
Inflammation and swelling of the hind paw of the rat were produced by the interdigital injection of either 0.1 ml of diluted (1: 4 v/v) LH, or 100 ,ug CS dissolved in 0-1 ml distilled water. Ten nmin later 10 W-256 cells suspended in 0-1 ml Tyrode solution were injected into the swollen paw and also into the contralateral (untreated) paw. In a group of 6 rats injected with LH palpable, actively growing. haemorrhagic tumours developed in the treated paws of 5 rats and no tumours in untreated paws. The 5 tumours were 2-10 mm in diameter at 21 days and continued to increase in size for a further 7 days when the rats were sacrificed. In the 6 rats treated with CS similar sized tumours grew in 4 treated paws, and in one rat a small tumour (2 mm in diameter) had developed in the untreated paw but was regressing. In similar groups of rats injected with 33 or 100 W-256 cells tumours developed in both the treated (CS or LH injected) and untreated paws of all rats, but larger tumours were present in the treated paws of most rats, particularly in the group injected with LH. (Di Rosa et al., 1971) . The most important known mediators of inflammation are the biogenic amines. histamine and 5-hydroxytryptamine, the peptide bradykinin and a group of cyclic oxygenated C20 fatty acids the prostaglandins (Brocklehurst. 1971) ; other pharmacologically active substances have been extracted from tissues, such as SRS (" slow reacting substance "). but their role in inflammation is less certain.
Since inflammation produced by tissue damage is the prelude to regeneration and repair, which involves blastogenesis and proliferative cell growth, it is reasonable to suppose that acute inflammatory exudates not only facilitate the growth of normal tissue (repair) but might act similarly with respect to tumour cells owing to the presence of growth promoting substances (GSS (van den Brenk and Kelly, 1973c) . The principal effect of x-rays on tissues is inhibition of proliferative cell growth; this results in cell death which stimulates inflammation. We consider this inflammatory state to be the principal cause of stimulation of tumour growth in tissues damaged by x-rays and other forms of injury.
The fact that treatment of rats with anti-inflammatory steroids decreased stimulation of tumour CFE produced by x-rays (van den Brenk et al., 1974) and by CS (Table I) (Wood, Holyoke and Yardley, 1961) . Also, it has been suggested that the presence of fibrin and thromboplastin are important in increasing take and growth of transplanted tumours (Grossi, Agostino and Cliffton, 1960; Hewitt, Blake and Porter, 1973) . Clotting of blood and laying down of fibrin also provides a support for the growth of regenerating blood vessels (Stearns. 1940a, b) . However, CFE of tumour cells in the lungs was not affected by anticoagulant treatment with mucous heparin, and was greatly stimulated by CS. a synthetic heparin which is a powerful anticoagulant and also increases fibrinolysis (Rothschild, 1968 (Stoker, 1973; Dulbecco and Elkington, 1973) . It is suggested that the capacity of different types of tumours to produce GSS varies widely and may be a quality closely related to that of malignant (autonomous) behaviour of a tumour and may also affect the chances of survival and clonogenicity of seeded tumour cells. The feeder cell phenomenon in vitro (Puck and Marcus, 1956 ) and the Revesz phenomenon in vivo (Revesz, 1956) Similarly. inflammatory reactions induced by the injury and death of normal tissues being replaced by growth of solid tumours may contribute to "invasiveness" and progressive growth of solid tumours, even when immunity has developed. Indeed, to a limited extent tumour antigenicity conceivably favours the " take ", growth and spread of the tumour cell.
The mechanism involved in " cocarcinogenesis " appears to be closelv related to and perhaps wholly due to a nonspecific growth promoting effect of inflammation of tissues caused by "cocarcinogens "; agents which have been defined as physical or chemical agents which " alone are not carcinogens, when applied along with or after the application of carcinogenic agents may increase the carcinogenic effect ", and " precipitate neoplasia in an area of tissue already prepared for it by the previous application of carcinogens " (Willis. 1950) . This interpretation of cocarcinogenesis is in agreement with that of Menkin (1961) , who prepared a diffusible growth promoting factor from inflammatory exudates induced in rats, which was heat stable and inactivated bv ribonuclease and trypsin, and acted as a cocarcinogen in mice and rabbits. Menkin reasoned that the liberation of endogenous GSS by inflammation offered a reasonable explanation for the induction of repair (regenerative growth). He also showed that the growth promoting activity of dialysates prepared from tissues of young (actively growing) animals was more pronounced than that of mature tissues. We consider that the rapid decrease in tumour CFE which occurs with decrease in growth rate of the rat after weaning (van den Brenk et al., 1973a ) is largely attributable to the same mechanisms, namely, a decrease in tissue GSS. Also, we suggest that the well established effects of injury of stimulating growth and of precipitating the clinical (overt) manifestation of cancer in organs such as breast. bone, testis and skin in man (Willis, 1948) are due primarily to the local growth promoting action of inflammation induced by the injury and do not basically difer from "cocarcinogenesis ".
